Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
Sales rise 9.67% to Rs 1041.26 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales1041.26949.42 10 OPM %35.6630.75 -PBDT402.27326.90 23 PBT381.95308.10 24 NP295.62229.88 29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content